Trials / Terminated
TerminatedNCT00004728
Aspirin Or Warfarin To Prevent Stroke
Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS) · NIH
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.
Detailed description
Prevention of stroke in patients with narrowing of one of the arteries in the brain typically consists of using medications to prevent blood clots from forming. Currently, the best medication to use in this situation is unknown. The purpose of this study is to compare the effectiveness of two different medications, warfarin or aspirin, for the prevention of stroke due to narrowing of one of the large arteries in the brain. Patients must have experienced a recent transient ischemic attack (TIA) or mild stroke. Stroke of this type is thought to occur more often in minorities.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Warfarin | |
| DRUG | Aspirin |
Timeline
- Completion
- 2003-07-01
- First posted
- 2000-02-28
- Last updated
- 2006-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00004728. Inclusion in this directory is not an endorsement.